In the intricate world of venous treatments, few methods have garnered as much attention and acclaim as CHIVA. As someone who has dedicated years to unraveling the complexities of venous health, I’ve come to appreciate the nuances that set pioneering treatments apart. Today, I’m honored to sit down with the very mind behind CHIVA, Professor Franceschi, to delve into its origins, its global impact, and what the future holds.
Alex: Professor Franceschi, it’s a pleasure to have this conversation with you. To start, how would you describe the global dissemination trend of CHIVA treatment?
Professor Franceschi: Geographical distribution is widespread in several countries. Every practitioner is won over by the method and its results. However, many specialists remain influenced by older, more destructive concepts, often backed by the marketing of endovenous destruction products.
Alex: When juxtaposed with traditional methods, what unique advantages does CHIVA bring to the table?
Professor Franceschi: The advantages of CHIVA over traditional methods are numerous. Comparative studies from various global teams have consistently shown CHIVA’s superiority in terms of recurrence and complications. Furthermore, CHIVA emphasizes the importance of preserving the saphenous vein, which could be pivotal for future treatments of life-threatening arterial diseases.
Alex: With CHIVA’s rising global prominence, have you observed any disparities in its acceptance across different regions?
Professor Franceschi: The acceptance of CHIVA varies based on socio-economic and cultural factors. The method challenges practitioners to re-evaluate their habits and knowledge. This, combined with the aggressive marketing of saphenous destruction products, explains the varied adoption rates across different regions.
Alex: How instrumental is the role of training and certification in CHIVA’s success?
Professor Franceschi: It’s of utmost importance. CHIVA’s success is not just about the technique but also the expertise of the medical practitioners. High-quality training by experts is essential.
Alex: Could you elaborate on CHIVA’s global training system?
Professor Franceschi: Operated by Inteleos and Dr. Smile Medical
Group, CHIVA’s training system emphasizes both theoretical and practical teaching, ensuring practitioners are adept at implementing the method.
Alex: As we look to the horizon, how do you envision the evolution of CHIVA with the advent of medical technological advancements?
Professor Franceschi: Technological advancements are a double-edged sword. They can enhance the method but can also distort it. However, I’m optimistic about younger generations adopting CHIVA.
Alex: In wrapping up, what are your aspirations for CHIVA’s global trajectory in the upcoming years?
Professor Franceschi: Scientific progress takes time to be accepted. With CHIVA’s scientific foundations now demonstrated, I believe younger generations open to progress will embrace it.
Alex: Professor Franceschi, it’s been enlightening to gain insights directly from the pioneer of CHIVA. As we continue to explore the frontiers of venous health, conversations like these are invaluable in bridging the gap between innovation and application. Thank you for sharing your expertise with us.
Dr. Smile Medical Group is the largest chain of vein centers in Asia, founded in 2014 and headquartered in Shanghai. With a presence in 13 cities across China, including Beijing, Guangzhou, and Shanghai, the group has established itself as a pioneer in the use of cutting-edge technology for the diagnosis and treatment of various types of varicose veins. Dr. Smile’s personalized approach includes a hemodynamic assessment and a focus on different types of varicose veins, ensuring that each patient receives customized treatment. The group is also responsible for the CHIVA global certification and training program, demonstrating its dedication to excellence in the field of venous care. With thousands of patients treated every year, Dr. Smile has become a leading authority in the field, and its experts are regularly invited to participate in CME and global venous forums to share their expertise and insights with fellow practitioner.